Abingworth, an international VC firm dedicated to life sciences and healthcare, has announced the promotions of Ken Haas and Vin Miles to partner. They both source and manage deals, including early-stage and late-stage venture capital, venture growth and VIPEs (venture investments in public equities). Mr. Haas, who is based in the firm's Menlo Park office, has spent 25 years in the management of early-stage and public technology and biotechnology companies, and is on the Board of a number of Abingworth's portfolio companies. Prior to joining Abingworth in 2007, Mr. Miles, based in Boston, served as senior vice president, Business Development, of Alnylam Pharmaceuticals (an Abingworth portfolio company).